American Society of Clinical Oncology

SHERPA: White

People

  1. Hensley
    Hensley
  2. Aghajanian
    Aghajanian
  3. O'Cearbhaill
    O'Cearbhaill
  4. Grisham
    Grisham
  5. Konner
    Konner
  6. Tew
    Tew
  7. Makker
    Makker
  8. Sabbatini
    Sabbatini
  9. Iasonos
    Iasonos
  10. Solit
    Solit

Groups

  1. Department of Medicine (6)
  2. Early Drug Development Service (6)
  3. GDMT, Medicine (6)
  4. Gynecologic Medicine Service (6)
  5. Gynecology Disease Management Team (6)
  6. Solid Tumor Oncology Division (6)
  7. Hematologic Malignancies, Division of (5)
  8. Human Oncology and Pathogenesis Program (4)
  9. GDMT, Pathology and Laboratory Medicine (3)
  10. GSK Faculty (3)
Search Within
  1. "David Hyman"
  2. "Meeting abstract"
  3. "Martee Hensley"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. Early Drug Development Service (6)
  3. GDMT, Medicine (6)
  4. Gynecologic Medicine Service (6)
  5. Gynecology Disease Management Team (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. David Hyman (6)
  2. Martee Hensley (6)
  3. Carol Aghajanian (5)
  4. Roisin O'Cearbhaill (5)
  5. Jason Konner (4)
  6. Rachel Grisham (4)

More People

Years
  1. 2018 (1)
  2. 2017 (2)
  3. 2015 (3)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D)
    Meeting Abstract

    Hyman, D. M.; Sill, M.; Cho, J. K.; Lankes, H. A.; Piekarz, R.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save